THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $9,526,000 | -0.2% | 9,790,000 | -1.0% | 0.02% | -11.8% |
| Q1 2020 | $9,543,000 | +28.0% | 9,890,000 | +31.9% | 0.02% | +30.8% |
| Q2 2018 | $7,453,000 | -36.3% | 7,500,000 | -34.8% | 0.01% | -35.0% |
| Q1 2018 | $11,693,000 | -14.7% | 11,500,000 | -8.0% | 0.02% | -13.0% |
| Q4 2017 | $13,710,000 | -10.8% | 12,500,000 | 0.0% | 0.02% | -17.9% |
| Q3 2017 | $15,367,000 | -9.2% | 12,500,000 | 0.0% | 0.03% | -12.5% |
| Q2 2017 | $16,929,000 | – | 12,500,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 6,000,000 | $5,827,000 | 3.55% |
| DeepCurrents Investment Group LLC | 21,223,000 | $20,803,000 | 1.80% |
| ZAZOVE ASSOCIATES LLC | 19,230,000 | $18,725,000 | 1.77% |
| Mohican Financial Management, LLC | 500,000 | $494,000 | 1.61% |
| Castle Creek Arbitrage, LLC | 5,149,000 | $5,015,000 | 1.47% |
| LINDEN ADVISORS LP | 62,688,000 | $61,071,000 | 1.40% |
| Verition Fund Management LLC | 10,817,000 | $10,504,000 | 0.41% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,100,000 | $23,451,000 | 0.32% |
| Baupost Group | 30,000,000 | $29,213,000 | 0.24% |
| SSI INVESTMENT MANAGEMENT LLC | 2,763,000 | $2,676,000 | 0.22% |